Hookworm (Necator americanus) larval enzymes disrupt human vascular endothelium.
Knowledge of the molecular mechanisms used by Necator americanus larvae to penetrate the human skin and the vasculature would aid the development of effective vaccines against this important pathogen. In this work, the impact of N. americanus exsheathing fluid (EF) and excretory/secretory products (ES) on the endothelial barrier was examined using human umbilical vein endothelial cells (HUVEC). Cellular responses were assessed by investigating molecular changes at cell-cell junctions and by determining levels of secreted IL-6, IL-8, and vascular endothelial growth factor (VEGF) in the culture medium. It would appear that a repertoire of larval proteases caused a dose-related increase in endothelial permeability as characterized by a decrease in monolayer resistance with increased permeation of tracer-albumin. These barrier changes were associated with disruption of junctional vascular endothelial cadherin (VE-cadherin) and F-actin and an increase in endothelial secretion of IL-6 and IL-8. Our data suggest that larval proteases play an important role in negotiating the endothelium.
Souadkia
Nahed
N
Division of Molecular and Cellular Science, Immune Modulation, Boots Science Building, School of Pharmacy, University of Nottingham, Nottingham, UK. paxns@nottingham.ac.uk
Brown
Alan
A
Leach
Lopa
L
Pritchard
David I
DI
D000723:Ancylostomatoidea / Q000254:growth & development*; D000818:Animals; D002463:Cell Membrane Permeability; D002478:Cells, Cultured; D003470:Culture Media; D004591:Electrophoresis, Polyacrylamide Gel; D004730:Endothelium, Vascular / Q000473:pathology*; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007365:Intercellular Junctions; D015850:Interleukin-6 / Q000378:metabolism; D016209:Interleukin-8 / Q000378:metabolism; D007814:Larva / Q000201:enzymology*; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism
D003470:Culture Media; D015850:Interleukin-6; D016209:Interleukin-8; D042461:Vascular Endothelial Growth Factor A
J Infect Dis. 1996 Jun;173(6):1460-6
8648220
Int J Dev Biol. 2000;44(6):743-8
11061439
Parasitology. 1975 Feb;70(1):25-38
235107
Biochemistry. 2004 May 11;43(18):5360-9
15122902
J Parasitol. 1992 Oct;78(5):917-9
1403440
Am J Physiol Lung Cell Mol Physiol. 2000 Sep;279(3):L419-22
10956614
Clin Microbiol Rev. 2001 Oct;14(4):689-703, table of contents
11585781
Toxicol In Vitro. 1999 Aug-Oct;13(4-5):789-95
20654551
J Matern Fetal Neonatal Med. 2009 Apr;22(4):325-31
19089771
Biochem J. 2001 Jul 1;357(Pt 1):107-15
11415441
J Cell Sci. 1999 Jun;112 ( Pt 12):1915-23
10341210
Parasite Immunol. 2004 Nov-Dec;26(11-12):443-54
15771680
Nephrol Dial Transplant. 1993;8(10):1129-32
8272228
Electrophoresis. 2000 Nov;21(17):3666-72
11271485
Infect Immun. 1995 May;63(5):1999-2003
7729914
J Clin Invest. 2002 Apr;109(8):1057-63
11956243
Infect Immun. 1992 Mar;60(3):1018-23
1541516
Int J Parasitol. 1992 Aug;22(5):563-72
1399239
J Clin Invest. 1973 Nov;52(11):2745-56
4355998
PLoS Negl Trop Dis. 2008 Jul 16;2(7):e262
18629379
Am J Trop Med Hyg. 1999 May;60(5):840-7
10344662
Mol Biol Cell. 2007 Dec;18(12):5014-23
17928406
Microvasc Res. 2001 Jan;61(1):87-101
11162199
Blood. 2004 Nov 15;104(10):3214-20
15271797
J Cell Sci. 1998 Jul;111 ( Pt 13):1853-65
9625748
J Biol Chem. 2004 Aug 20;279(34):35950-7
15199048
J Helminthol. 1984 Sep;58(3):207-12
6542116
Microvasc Res. 1995 Nov;50(3):323-37
8583948
Am J Physiol Regul Integr Comp Physiol. 2007 Apr;292(4):R1563-8
17158262
Am J Physiol. 1999 Nov;277(5):L1057-65
10564193
J Anat. 2002 Jun;200(6):561-74
12162724
J Anat. 2002 Jun;200(6):541-8
12162722
Am J Physiol. 1997 Jul;273(1 Pt 2):H286-94
9249502
J Cell Biol. 1995 Apr;129(1):203-17
7698986